OIDIX
Price
$17.93
Change
+$0.01 (+0.06%)
Updated
Oct 17 closing price
Net Assets
1.48B
RERHX
Price
$64.78
Change
-$0.27 (-0.42%)
Updated
Oct 17 closing price
Net Assets
137.06B
Interact to see
Advertisement

OIDIX vs RERHX

Header iconOIDIX vs RERHX Comparison
Open Charts OIDIX vs RERHXBanner chart's image
Invesco International Diversified R6
Price$17.93
Change+$0.01 (+0.06%)
VolumeN/A
Net Assets1.48B
American Funds EUPAC R5E
Price$64.78
Change-$0.27 (-0.42%)
VolumeN/A
Net Assets137.06B
OIDIX vs RERHX Comparison Chart in %
View a ticker or compare two or three
VS
OIDIX vs. RERHX commentary
Oct 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OIDIX is a Hold and RERHX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RERHX has more cash in the bank: 137B vs. OIDIX (1.48B). OIDIX pays higher dividends than RERHX: OIDIX (1.93) vs RERHX (0.80). OIDIX was incepted earlier than RERHX: OIDIX (13 years) vs RERHX (10 years). OIDIX (0.92) is less costly to investors than RERHX (0.62). RERHX is a more actively managed with annual turnover of: 35.00 vs. OIDIX (8.00). RERHX has a lower initial minimum investment than OIDIX: RERHX (250) vs OIDIX (1000000). RERHX annual gain was more profitable for investors over the last year : 11.27 vs. OIDIX (5.34). RERHX return over 5 years is better than : 14.66 vs. OIDIX (-7.83).
OIDIXRERHXOIDIX / RERHX
Total Expense Ratio0.920.62148%
Annual Report Gross Expense Ratio0.920.62148%
Fund Existence13 years10 years-
Gain YTD17.19021.65379%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.48B137B1%
Annual Yield % from dividends1.930.80241%
Returns for 1 year5.3411.2747%
Returns for 3 years24.3549.4249%
Returns for 5 years-7.8314.66-53%
Returns for 10 years37.03N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CYTOF0.100.02
+23.63%
Altamira Therapeutics Ltd.
KNGRF1.230.04
+2.98%
Kingsmen Resources Ltd.
OQLGF2.30N/A
N/A
Olympique Lyonnais Groupe
PEXNY8.90N/A
N/A
PTT Exploration & Production Public Co., Ltd.
BRCTF32.16N/A
N/A
BIOARCTIC AB